Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Applications are now open for the Wellcome Trust Infection, Immunology, and Translational Medicine DPhil programme.

THIS ROUND IS NOW CLOSED.

This programme delivers novel, integrated graduate training in infection and immunology within a translational medicine context. It provides the opportunity for research in the basic biomedical sciences of infectious diseases, the innate and acquired immune system and the development and use of therapeutic drugs and vaccines. It consists of a one-year modular course followed by a three-year doctoral research project, which can take place in any of the participating departments at the University.

Further details of the course entry requirements, funding and costs, and how to apply, are available here.

Applicants are also strongly advised to visit the Medical Sciences Graduate School website to help them identify the most suitable course and supervisors.

The course is integrated around three themes:

  • immunology
  • infection
  • translational medicine

In the first year you will undergo three 12-week laboratory rotations and a series of training courses relevant to your work. You will be advised on your choice of courses and laboratory rotation to help tailor an individual student package.

In the second year you will initiate your DPhil project from the large number of projects available; a list of participating supervisors is available on the MSDTC website. This choice will be aided by your exposure to potential DPhil supervisors and scientific areas during the first year. Programme directors will also guide you through this process.

You will present your work from your three rotations to the management committee. Each rotation will be assessed in a different format.  The first rotation will involve an oral presentation, the second a poster presentation and the third rotation a written report. There is no formal progression mark towards the final three years; however you have to write a small grant proposal at the end of the rotation year. 

In your second year you will write a literature review on a selected topic. Many of these reviews have been published in scientific literature. You will be required to meet standard University milestones for progress and will be monitored formally via supervisor feedback forms submitted three times per year.

Similar stories

Study raises hope of pre-school type 1 diabetes screening programme

Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.

Oxford to work with Brazil to establish clinical research hub

The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.

New atlas revealed of bone marrow haematopoiesis during development

A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.